Clinical Trial

Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis

Study acronym: MG-ARCADIA
Recruiting
View on ClinicalTrials.gov →
Summary
The Polish multicentre observational (non-interventional) study aiming to collect data on the management and clinical outcomes of patients with gMG that received ravulizumab.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2025-03-27; most recent amendment 2026-06-17.
Status change: Not Yet Recruiting → Recruiting 2025-05-20
Trial Details
NCT Number NCT06909253
Lead Sponsor AstraZeneca
Conditions Myasthenia Gravis, Generalized
Enrollment 50 participants
Start Date 2025-05-15
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-14